Zimmer Biomet stock rises 2.95% and outperforms competitors

11 articles · Updated · MarketWatch · Apr 30

The shares closed at $82.43 on Thursday, beating Johnson & Johnson's 1.10% gain, Medtronic's 2.02% rise and unchanged Stryker shares.
The advance ended a two-day losing streak during a broader market rally, with the S&P 500 up 1.02% and the Dow Jones Industrial Average up 1.62%.
Trading volume reached 4.2 million shares, above the 50-day average of 2.2 million, though the stock remains 23.88% below its 52-week high of $108.29.

Can record earnings and new robotics overcome the risk of a sudden leadership shakeup at this medical tech giant?

Is Zimmer Biomet's stock a deep value buy or a classic value trap after its recent market volatility?